CELEX: 32014M7114
Language: en
Date: 2014-02-04 00:00:00
Title: Commission Decision of 04/02/2014 declaring a concentration to be compatible with the common market (Case No COMP/M.7114 - JLL / DSM / JV) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

|[pic]                             |EUROPEAN COMMISSION                                                                                      |
|                                  |                                                                                                         |
|                                  |                                                                                                         |
|                                  |                                                                                                         |
|                                  |                                                                                                         |

                                        Brussels, 04.02.2014
                                        C(2014) 731 final

|To the notifying parties:                                          |                                                                   |                                                                   |                                                                   |

Dear Madam/Sir,

Subject:    Case No COMP/M.7114 - JLL/DSM/JV
Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004[1]

 1. On 8 January 2014, the European Commission received notification of a proposed concentration pursuant to Article 4 of the  Merger  Regulation
    by which the undertaking JLL Patheon Co-Investment Fund, L.P. ("JLL Holdco"), an affiliate of JLL Partners ("JLL") and  Koninkijke  DSM  N.V.
    ("DSM") will create a joint venture ("JV") within the meaning of Article 3(4) of the Merger Regulation through a multi-step  transaction  and
    the contribution of certain businesses, assets and cash[2].

 2. The business activities of the undertakings concerned are:

      -     for JLL:  private  equity  firm  holding  investments  in  various  industries  including  pharmaceutical  contract  development  and
           manufacturing outsourcing;

      -     for DSM: a global science-based company active in health, nutrition and materials;

      -     for JV: pharmaceutical contract development and manufacturing outsourcing.

 1. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger
    Regulation and of paragraph 5(c) of the Commission Notice on a simplified procedure for treatment of  certain  concentrations  under  Council
    Regulation (EC) No 139/2004[3].

 2. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and
    to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article  6(1)(b)  of
    the Merger Regulation.

                                        Signed

                                        For the Commission

                                        Alexander ITALIANER
                                        Director General

-----------------------
[1]   OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the  European  Union
      ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by  "internal  market".  The
      terminology of the TFEU will be used throughout this decision.
[2]   Publication in the Official Journal of the European Union No C 12, 16.01.2014, p. 5-5.
[3]   OJ C 366, 14.12.2013, p. 5.

-----------------------
                                                                  PUBLIC VERSION

                                                           SIMPLIFIED MERGER PROCEDURE